These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5047490)

  • 1. [The influence of rifampicin therapy on oral anticoagulation with acenocoumarol].
    Beran G
    Prax Pneumol; 1972 Jun; 26(6):350-3. PubMed ID: 5047490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the influence of rifampin on the anticoagulant effect of acenocoumarol].
    Sennwald G
    Rev Med Suisse Romande; 1974 Nov; 94(11):945-54. PubMed ID: 4438871
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetic study of factor X during oral anticoagulation with acenocoumarol: potential value for the initiation of treatment.
    Aiach M; Fiessinger JN; Capron L; Nussas C; Housset E; Leclerc M
    Thromb Haemost; 1982 Feb; 47(1):69-71. PubMed ID: 7071808
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with endobronchial and local use of rifampicin in tuberculosis].
    Abdurashitova MV; Stoianovskiĭ EA; Fok AIa
    Probl Tuberk; 1976 Jan; (l):35-8. PubMed ID: 995905
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of oral and intravenous rifampicin administration in the treatment of open pulmonary tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; von Sassen W; Labedzki L; Schwabe HK; Hengstmann J; Eichelbaum M
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():482-4. PubMed ID: 6647280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Corrective possibilities of rifampicin in ineffective chemotherapy of destructive pulmonary tuberculosis in children and adolescents].
    Ivaniuta OM; Il'nitskiĭ IG; Panasiuk AV; Kunichkina SA
    Probl Tuberk; 1987; (8):30-3. PubMed ID: 3684986
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
    Adamovich VN; Kolomytseva OS; Gur'ian IE
    Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental and clinical studies of rifampicin in tuberculosis.
    Konno K; Oizumi K; Hayashi I; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of rifampicin with phenprocoumon (author's transl)].
    Held H
    Dtsch Med Wochenschr; 1979 Sep; 104(37):1311-4. PubMed ID: 477551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Condition of the liver in patients with chronic pulmonary tuberculosis receiving a combination of antibacterial drugs including rifampicin and ethambutol].
    Kondrat'eva VI; Umarova MK; Arifkhanova SI
    Probl Tuberk; 1977; (2):35-40. PubMed ID: 866309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver function in patients with chronic destructive pulmonary tuberculosis during complex treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Chertkova MA; Pavlenko AV
    Probl Tuberk; 1975; (10):44-8. PubMed ID: 1208440
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifampicin in the treatment of chronic pulmonary tuberculosis. Preliminary report].
    Pacheco CR; Cordero O; López-Malagón S; Sierra D; De Jesús Pacheco M; Vázquez E
    Gac Med Mex; 1973 Jun; 105(6):541-7. PubMed ID: 4731993
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of ethambutol and rifampicin on sputum conversion in chronically infectious patients].
    Juchniewicz M; Radecki A; Kowalczyk H; Grzywacz W
    Gruzlica; 1974 May; 42(5):397-400. PubMed ID: 4464226
    [No Abstract]   [Full Text] [Related]  

  • 17. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Chukanov VI
    Probl Tuberk; 1978 Jun; (6):14-20. PubMed ID: 353801
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampicin--ethambutol in retreatment of pulmonary tuberculosis.
    Mital OP; Narang RK; Sachan AS
    Indian J Chest Dis Allied Sci; 1976 Jul; 18(3):141-5. PubMed ID: 1026643
    [No Abstract]   [Full Text] [Related]  

  • 20. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.